Physician profile
Bernardo M Utset
NPI 1770585184
$15,290.29
in general payments reported to CMS, 2019-2025
39 companies · $23.26 in 2025
The $23.26 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,043 · 2020: $2,046 · 2021: $3,056 · 2022: $3,323 · 2023: $4,051 · 2024: $747 · 2025: $23.26.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,822.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,821.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,964.00 | 2021-2024 | Onyx Frontier, Amplia Mri Quad Crt-D Surescan, Hawkone |
| Abiomed | $2,309.18 | 2019-2024 | Impella |
| Medtronic Vascular, INC. | $1,668.81 | 2019-2020 | |
| Inari Medical, INC. | $872.09 | 2022-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Abbott Laboratories | $844.07 | 2019-2023 | Amplatzer Amulet, Mitraclip, Diamondback Coronary |
| Boston Scientific Corporation | $762.50 | 2019-2025 | Watchman Flx, Wolverine Coronary Cutting Balloon, Rotapro |
| Edwards Lifesciences Corporation | $606.91 | 2022-2024 | Sapien 3 Ultra Resilia |
| Amgen INC. | $600.50 | 2019-2023 | Repatha |
| Janssen Pharmaceuticals, INC | $460.00 | 2019-2022 | |
| Acist Medical Systems, INC. | $418.92 | 2019-2021 | |
| Cardiovascular Systems INC. | $409.35 | 2019-2023 | Diamondback Coronary |
| Pfizer INC. | $373.45 | 2019-2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $294.92 | 2019-2023 | Lifevest |
| Actelion Pharmaceuticals US, INC. | $263.09 | 2020-2021 | |
| Novo Nordisk INC | $240.06 | 2021-2023 | Rybelsus, Ozempic |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $221.09 | 2019-2023 | Wainua |
| Merck Sharp & Dohme LLC | $111.50 | 2021-2023 | Verquvo |
| Cvrx, INC. | $103.51 | 2021-2022 | |
| Shockwave Medical, INC | $87.60 | 2021-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Biotronik INC. | $75.79 | 2021 | |
| Impulse Dynamics (USA) INC. | $61.09 | 2022-2023 | Optimizer |
| Amarin Pharma, INC. | $52.38 | 2019-2021 | |
| Teleflex LLC | $52.22 | 2022-2023 | Manta |
| Sanofi-Aventis U.S. LLC | $50.75 | 2019 | |
| Astellas Pharma US INC | $45.38 | 2019-2021 | |
| W. L. Gore & Associates, INC. | $39.03 | 2023 | Gore Cardioform Septal Occluder |
| Esperion Therapeutics, INC. | $38.25 | 2020-2021 | |
| Gilead Sciences, INC. | $32.95 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $29.88 | 2019-2024 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $28.12 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $27.72 | 2021-2022 | |
| Baxter Healthcare | $27.71 | 2023 | Hillrom - Cardiac Ambulatory Monitor, Hillrom - Carnation Ambulatory Monitor |
| Kowa Pharmaceuticals America, INC. | $19.25 | 2021 | |
| Zoll Circulation INC | $18.99 | 2021 | |
| Terumo Medical Corporation | $18.34 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $17.77 | 2023 | Inpefa |
| Alnylam Pharmaceuticals INC. | $16.89 | 2021 | |
| Arbor Pharmaceuticals, INC. | $13.40 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $12.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bernardo Utset listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.